Pharmaceuticals news continually updated from thousands of sources around the net.
1 hr ago | Business Wire
The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player.
Trending on the Topix Network
5 hrs ago | Mail & Guardian
From multivitamins to fish oil, daily pills and powders have become routine for millions around the world.
Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE , the generic version of Janssen Pharmaceuticals Inc.'s ORTHO EVRA * .
State Sen. Hannah-Beth Jackson , D-Santa Barbara, announced on Wednesday that, due to a lack of support from some of her legislative colleagues in the Senate Business, Professions and Economic Development Committee, she is shelving a bill this year to create the nation's first statewide drug take-back program for prescription and over-the-counter ... (more)
Other equities research analysts have also recently issued reports about the stock.
The firm set a "neutral" rating on the stock. TEVA has been the subject of a number of other recent research reports.
Research and Markets: Global Testicular Cancer Drugs Market 2014-2018 With Bristol-Myers Squibb, Hospira, Teva Pharmaceutical Industries & ZIOPHARM Oncology Dominating )--Research and Markets has announced the addition of the "Global Testicular Cancer Drugs Market 2014-201... )--Research and Markets has announced the addition of the "Global ... (more)
The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.
S&P SmallCap 600 constituent Akorn Inc. is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.
Does Merck stand a chance? Merck has lagged the hepatitis C race, but the phase 2 results from its oral combination of MK-5172 and MK-8742 in genotype 1 patients are quite impressive.
Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated for the treatment of insomnia.
Today, Analysts Review released its analysts' notes regarding CSX Corp. , Cardinal Health, Inc. , L Brands, Inc. , Discovery Communications, Inc. and CH Robinson Worldwide Inc. .
A new drug application has been submitted to the FDA for a fixed-dose combination of atazanavir sulfate, a protease inhibitor marketed as Reyataz , and cobicistat , an investigational pharmacokinetic enhancer, or boosting agent, that can increase the level of certain human immunodeficiency virus-1 medications in the blood and make them more ... (more)
Generic drugmaker Akorn Enterprises Inc has won U.S. antitrust approval to buy rival Hi-Tech Pharmacal Inc on condition that it sell three generic prescription eye medications and two generic topical anesthetics, the Federal Trade Commission said on Monday.
Police, firefighters and emergency personnel responded to a call about 10 a.m. Monday.
Today RelayHealth Financial a announced it has received the NorthFace ScoreBoard AwardSM in recognition of excellence in customer service and support for its RelayAssurancea and RelayClearancea revenue cycle management solutions.